Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neoplasms of the CNS
  Free Subscription

Articles published in
Oncogene
    October 2025
  1. UPRETI M, Petrosyan A, Thornton ME, Hovsepyan A, et al
    Multicellular tumor-stromal interactions recapitulate aspects of therapeutic response and human oncogenic signaling in a 3D disease model for H3K27M-altered DIPG.
    Oncogene. 2025;44:3694-3712.
    >> Share

    August 2025
  2. LEE H, Kim D, Kim B, Shin E, et al
    Membrane flexibility induced by BST2 contributes to radioresistance in glioblastoma.
    Oncogene. 2025 Aug 18. doi: 10.1038/s41388-025-03544.
    >> Share

  3. VIGNEUL E, Krins F, Clotman F
    Of travelling homeoproteins and medulloblastomas.
    Oncogene. 2025 Aug 4. doi: 10.1038/s41388-025-03523.
    >> Share

    July 2025
  4. ZHANG S, Zhang L, Guan N, Feng X, et al
    Unveiling the role of TAM-derived extracellular vesicles in glioma progression through Treg polarization and immune suppression.
    Oncogene. 2025 Jul 18. doi: 10.1038/s41388-025-03497.
    >> Share

  5. LIU L, Wang R, Cheng K, Bai C, et al
    Steroid receptor coactivator-1 facilitates METTL3-mediated m6A modification by coactivating NF-kappaB and promotes the malignant progression of glioblastoma.
    Oncogene. 2025 Jul 15. doi: 10.1038/s41388-025-03494.
    >> Share

  6. MAHADDALKAR T, Banerjee A, Ketkar M, Thorat R, et al
    Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence.
    Oncogene. 2025;44:2103-2115.
    >> Share

    June 2025
  7. BRISUDOVA P, Stojanovic D, Novak J, Nahacka Z, et al
    Correction: Functional mitochondrial respiration is essential for glioblastoma tumour growth.
    Oncogene. 2025 Jun 4. doi: 10.1038/s41388-025-03451.
    >> Share

    May 2025
  8. EL-SEHEMY A, Tachibana N, Ortin-Martinez A, Ringuette D, et al
    Importin-alpha transports Norrin to the nucleus to promote proliferation and Notch signaling in glioblastoma stem cells.
    Oncogene. 2025 May 27. doi: 10.1038/s41388-025-03427.
    >> Share

  9. CHEN Y, Ding K, Zheng S, Gao S, et al
    Post-translational modifications in DNA damage repair: mechanisms underlying temozolomide resistance in glioblastoma.
    Oncogene. 2025 May 26. doi: 10.1038/s41388-025-03454.
    >> Share

  10. BRISUDOVA P, Stojanovic D, Novak J, Nahacka Z, et al
    Functional mitochondrial respiration is essential for glioblastoma tumour growth.
    Oncogene. 2025 May 5. doi: 10.1038/s41388-025-03429.
    >> Share

    April 2025
  11. LAKKA SS, Gondi CS, Yanamandra N, Olivero WC, et al
    Retraction Note: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
    Oncogene. 2025 Apr 29. doi: 10.1038/s41388-025-03402.
    >> Share

  12. GONDI CS, Lakka SS, Dinh DH, Olivero WC, et al
    Retraction Note to: RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.
    Oncogene. 2025 Apr 29. doi: 10.1038/s41388-025-03403.
    >> Share

  13. LAKKA SS, Jasti SL, Gondi C, Boyd D, et al
    Retraction Note: Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
    Oncogene. 2025 Apr 25. doi: 10.1038/s41388-025-03397.
    >> Share

  14. REN F, Yi Y, Lu T, Liu X, et al
    Synthetic lethality through Gsk3beta inhibition in glioma stem cells via the WNT-WWC1-YAP axis.
    Oncogene. 2025 Apr 23. doi: 10.1038/s41388-025-03418.
    >> Share

  15. ADACHI Y, Chandrasekar N, Kin Y, Lakka SS, et al
    Retraction Note: Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.
    Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03385.
    >> Share

  16. YANAMANDRA N, Gumidyala KV, Waldron KG, Gujrati M, et al
    Retraction Note: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis.
    Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03405.
    >> Share

  17. CHANDRASEKAR N, Mohanam S, Gujrati M, Olivero WC, et al
    Retraction Note to: Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.
    Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03406.
    >> Share

  18. GONDI CS, Lakka SS, Yanamandra N, Siddique K, et al
    Retraction Note: Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Oncogene. 2025 Apr 10. doi: 10.1038/s41388-025-03401.
    >> Share

  19. KONDURI SD, Rao CN, Chandrasekar N, Tasiou A, et al
    Retraction Note: A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
    Oncogene. 2025 Apr 10. doi: 10.1038/s41388-025-03404.
    >> Share

  20. KARGIOTIS O, Chetty C, Gondi CS, Tsung AJ, et al
    Retraction Note to: Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma.
    Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03377.
    >> Share

  21. KONDURI SD, Osman FA, Rao CN, Srinivas H, et al
    Retraction Note: Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
    Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03384.
    >> Share

  22. LAKKA SS, Rajan M, Gondi C, Yanamandra N, et al
    Retraction Note: Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
    Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03395.
    >> Share

  23. MOHANAM S, Chintala SK, Go Y, Bhattacharya A, et al
    Retraction Note: In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
    Oncogene. 2025 Apr 8. doi: 10.1038/s41388-025-03393.
    >> Share

  24. YANAMANDRA N, Kondraganti S, Srinivasula SM, Gujrati M, et al
    Retraction Note: Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells.
    Oncogene. 2025 Apr 8. doi: 10.1038/s41388-025-03394.
    >> Share

  25. KOUL D, Parthasarathy R, Shen R, Davies MA, et al
    Retraction Note: Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.
    Oncogene. 2025 Apr 8. doi: 10.1038/s41388-025-03396.
    >> Share

  26. MOHANAM S, Jasti SL, Kondraganti SR, Chandrasekar N, et al
    Retraction Note: Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
    Oncogene. 2025 Apr 4. doi: 10.1038/s41388-025-03379.
    >> Share

    March 2025
  27. FENG H, Liu KW, Guo P, Zhang P, et al
    Retraction Note: Dynamin 2 mediates PDGFRalpha-SHP-2-promoted glioblastoma growth and invasion.
    Oncogene. 2025 Mar 3. doi: 10.1038/s41388-025-03313.
    >> Share

    February 2025
  28. POWELL AM, Watson L, Luzietti L, Prekovic S, et al
    The epigenetic landscape of brain metastasis.
    Oncogene. 2025 Feb 27. doi: 10.1038/s41388-025-03315.
    >> Share

  29. FENG H, Hu B, Vuori K, Sarkaria JN, et al
    Correction: EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.
    Oncogene. 2025 Feb 5. doi: 10.1038/s41388-025-03290.
    >> Share

    November 2024
  30. SUN B, Wang G, Chen G, Zhang Y, et al
    GNAO1 overexpression promotes neural differentiation of glioma stem-like cells and reduces tumorigenicity through TRIM21/CREB/HES1 axis.
    Oncogene. 2024 Nov 23. doi: 10.1038/s41388-024-03234.
    >> Share

  31. YU J, Han J, Yu M, Rui H, et al
    EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair.
    Oncogene. 2024 Nov 19. doi: 10.1038/s41388-024-03232.
    >> Share

    September 2024
  32. DAVE F, Herrera K, Lockley A, van de Weijer LL, et al
    Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
    Oncogene. 2024 Sep 26. doi: 10.1038/s41388-024-03177.
    >> Share

    August 2024
  33. DAVE F, Herrera K, Lockley A, van de Weijer LL, et al
    Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
    Oncogene. 2024 Aug 23. doi: 10.1038/s41388-024-03131.
    >> Share

  34. SONG Y, Zhang Y, Wang Z, Lin Y, et al
    CCL2 mediated IKZF1 expression promotes M2 polarization of glioma-associated macrophages through CD84-SHP2 pathway.
    Oncogene. 2024 Aug 7. doi: 10.1038/s41388-024-03118.
    >> Share

  35. HU J, Li X, Xu K, Chen J, et al
    CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A.
    Oncogene. 2024 Aug 4. doi: 10.1038/s41388-024-03116.
    >> Share

    July 2024
  36. SHAH K, Tang Y, Breakefield X, Weissleder R, et al
    Correction: Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
    Oncogene. 2024 Jul 23. doi: 10.1038/s41388-024-03109.
    >> Share

    May 2024
  37. XU L, Ye Y, Tao Z, Wang T, et al
    Correction: O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.
    Oncogene. 2024 May 21. doi: 10.1038/s41388-024-03045.
    >> Share

  38. XIE W, Wang J, Tian S, Zhao H, et al
    RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.
    Oncogene. 2024;43:1463-1475.
    >> Share

    February 2024
  39. SHENG H, Li H, Zeng H, Zhang B, et al
    Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.
    Oncogene. 2024 Feb 14. doi: 10.1038/s41388-024-02967.
    >> Share

    November 2023
  40. XU L, Ye Y, Tao Z, Wang T, et al
    O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.
    Oncogene. 2023 Nov 10. doi: 10.1038/s41388-023-02881.
    >> Share

    September 2023
  41. TU KJ, Stewart CE, Hendrickson PG, Regal JA, et al
    Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma.
    Oncogene. 2023 Sep 23. doi: 10.1038/s41388-023-02845.
    >> Share

    August 2023
  42. WAN S, Liu C, Li C, Wang Z, et al
    AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
    Oncogene. 2023 Aug 18. doi: 10.1038/s41388-023-02796.
    >> Share

    July 2023
  43. PAN JK, Lin WD, Kuo YL, Chen YC, et al
    ICAM2 initiates trans-blood-CSF barrier migration and stemness properties in leptomeningeal metastasis of triple-negative breast cancer.
    Oncogene. 2023 Jul 19. doi: 10.1038/s41388-023-02769.
    >> Share

  44. NAVICKAS SM, Giles KA, Brettingham-Moore KH, Taberlay PC, et al
    The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target.
    Oncogene. 2023;42:2363-2373.
    >> Share

    June 2023
  45. PIPERI C, Markouli M, Gargalionis AN, Papavassiliou KA, et al
    Deciphering glioma epitranscriptome: focus on RNA modifications.
    Oncogene. 2023 Jun 15. doi: 10.1038/s41388-023-02746.
    >> Share

  46. EISENBARTH D, Wang YA
    Glioblastoma heterogeneity at single cell resolution.
    Oncogene. 2023 Jun 5. doi: 10.1038/s41388-023-02738.
    >> Share

  47. LIANG XQ, Avraham HK, Jiang S, Avraham S, et al
    Retraction Note: Genetic alterations of the NRP/B gene are associated with human brain tumors.
    Oncogene. 2023 Jun 2. doi: 10.1038/s41388-023-02741.
    >> Share

  48. KAPOOR GS, O'Rourke DM
    Editorial Expression of Concern: SIRPa1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration.
    Oncogene. 2023 Jun 1. doi: 10.1038/s41388-023-02740.
    >> Share

    May 2023
  49. WEI J, Wang L, Zhang Y, Sun T, et al
    TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1.
    Oncogene. 2023 May 15. doi: 10.1038/s41388-023-02717.
    >> Share

  50. CORDNER R, Jhun M, Panwar A, Wang H, et al
    Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1.
    Oncogene. 2023 May 9. doi: 10.1038/s41388-023-02713.
    >> Share

  51. EL BABA R, Pasquereau S, Haidar Ahmad S, Monnien F, et al
    EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes.
    Oncogene. 2023 May 5. doi: 10.1038/s41388-023-02709.
    >> Share

  52. PAASSEN I, Williams J, Rios Arceo C, Ringnalda F, et al
    Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
    Oncogene. 2023;42:1661-1671.
    >> Share

    March 2023
  53. ZHOU P, Peng X, Tang S, Zhang K, et al
    E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.
    Oncogene. 2023 Mar 7. doi: 10.1038/s41388-023-02644.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016